Oaktree Acquisition Corp. III Life Sciences
For the period ended Dec 31, 2024. Filed Mar 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 27, 2025
OACC$10.70-0.2%Stored close · as of Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| PAGE | |
|---|---|
| CERTAIN TERMS | iii |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | v |
| PART I | 1 |
| ITEM 1. BUSINESS | 1 |
| ITEM 1A. RISK FACTORS | 36 |
| ITEM 1B. UNRESOLVED STAFF COMMENTS | 84 |
| ITEM 1C. CYBERSECURITY | 84 |
| ITEM 2. PROPERTIES | 84 |
| ITEM 3. LEGAL PROCEEDINGS | 85 |
| ITEM 4. MINE SAFETY DISCLOSURES | 85 |
| PART II | 86 |
| ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES | 86 |
| ITEM 6. [RESERVED] | 87 |
| ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 87 |
| ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK | 90 |
| ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA | 91 |
| ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE | 91 |
| ITEM 9A. CONTROLS AND PROCEDURES | 91 |
| ITEM 9B. OTHER INFORMATION | 91 |
| ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS | 91 |
i
| PART III | 92 |
|---|---|
| ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE | 92 |
| ITEM 11. EXECUTIVE COMPENSATION | 103 |
| ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS | 104 |
| ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE | 112 |
| ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES | 115 |
| PART IV | 116 |
| ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES | 116 |
| SIGNATURES | 118 |
| FINANCIAL STATEMENTS INDEX | F-1 |
ii
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.